A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 32, Pages 4140-4147
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-10-01
DOI
10.1200/jco.2012.48.5516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome-wide CpG island methylation analyses in non-small cell lung cancer patients
- (2012) Gerwin Heller et al. CARCINOGENESIS
- Key epigenetic changes associated with lung cancer development
- (2012) Heather H. Nelson et al. Epigenetics
- Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
- (2012) S. A. Selamat et al. GENOME RESEARCH
- Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia
- (2012) Rainer Claus et al. JOURNAL OF CLINICAL ONCOLOGY
- A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies
- (2012) Johannes R Kratz et al. LANCET
- Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients
- (2011) Ji Woong Son et al. CANCER LETTERS
- Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome
- (2011) Juan Sandoval et al. Epigenetics
- A DNA methylation fingerprint of 1628 human samples
- (2011) A. F. Fernandez et al. GENOME RESEARCH
- High density DNA methylation array with single CpG site resolution
- (2011) Marina Bibikova et al. GENOMICS
- Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome
- (2011) Angela Di Vinci et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Increased methylation variation in epigenetic domains across cancer types
- (2011) Kasper Daniel Hansen et al. NATURE GENETICS
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Differentiation of Lung Adenocarcinoma, Pleural Mesothelioma, and Nonmalignant Pulmonary Tissues Using DNA Methylation Profiles
- (2009) B. C. Christensen et al. CANCER RESEARCH
- Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
- (2009) Rodrigo Arriagada et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
- (2009) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
- (2009) Rafael A Irizarry et al. NATURE GENETICS
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
- (2008) Gary M. Strauss et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
- (2008) Malcolm V. Brock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started